|
FDA Misses MDUFA Deadline, Urged to Resolve Differences With Industry
Ranking members of the House and Senate committees charged with reauthorizing user fee legislation for medical devices used the FDA’s Jan. 13 delivery of three drug user fee agreements to nudge devicemakers and the FDA toward promptly issuing their own commitment letter.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives